These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Extrahepatic biliary stenoses after hepatic arterial infusion (HAI) of floxuridine (FUdR) for liver metastases from colorectal cancer. Aldrighetti L, Arru M, Ronzoni M, Salvioni M, Villa E, Ferla G. Hepatogastroenterology; 2001 Jan; 48(41):1302-7. PubMed ID: 11677951 [Abstract] [Full Text] [Related]
3. Biliary sclerosis in patients receiving hepatic arterial infusions of floxuridine. Hohn D, Melnick J, Stagg R, Altman D, Friedman M, Ignoffo R, Ferrell L, Lewis B. J Clin Oncol; 1985 Jan; 3(1):98-102. PubMed ID: 3155548 [Abstract] [Full Text] [Related]
14. Floxuridine-induced sclerosing cholangitis: an ischemic cholangiopathy? Ludwig J, Kim CH, Wiesner RH, Krom RA. Hepatology; 1989 Feb; 9(2):215-8. PubMed ID: 2521475 [Abstract] [Full Text] [Related]
15. Bile duct strictures associated with hepatic arterial infusion chemotherapy. Clark RA, Gallant TE. Gastrointest Radiol; 1987 Feb; 12(2):148-51. PubMed ID: 2951292 [Abstract] [Full Text] [Related]
16. Endoscopic biliary stent placement for bile duct stricture after hepatic artery infusion of 5-FUDR. Siegel JH, Ramsey WH. J Clin Gastroenterol; 1986 Dec; 8(6):673-6. PubMed ID: 2949002 [Abstract] [Full Text] [Related]
17. Fibrosis of extrahepatic biliary system after continuous hepatic artery infusion of floxuridine through an implantable pump (Infusaid pump). Haq MM, Valdes LG, Peterson DF, Gourley WK. Cancer; 1986 Apr 01; 57(7):1281-3. PubMed ID: 2936442 [Abstract] [Full Text] [Related]
18. Painful palmar and plantar erythema associated with hepatic artery infusion of 5-fluoro-2'deoxyuridine. Neuss MN, Akwari OE, Stevenson DF, Goodwin BJ. J Natl Med Assoc; 1987 Jun 01; 79(6):669-71. PubMed ID: 2956430 [Abstract] [Full Text] [Related]
19. Biliary sclerosis after hepatic arterial infusion pump chemotherapy for patients with colorectal cancer liver metastasis: incidence, clinical features, and risk factors. Ito K, Ito H, Kemeny NE, Gonen M, Allen PJ, Paty PB, Fong Y, Dematteo RP, Blumgart LH, Jarnagin WR, D'Angelica MI. Ann Surg Oncol; 2012 May 01; 19(5):1609-17. PubMed ID: 21989666 [Abstract] [Full Text] [Related]
20. Phase II trial of high-dose conformal radiation therapy with concurrent hepatic artery floxuridine for unresectable intrahepatic malignancies. Ben-Josef E, Normolle D, Ensminger WD, Walker S, Tatro D, Ten Haken RK, Knol J, Dawson LA, Pan C, Lawrence TS. J Clin Oncol; 2005 Dec 01; 23(34):8739-47. PubMed ID: 16314634 [Abstract] [Full Text] [Related] Page: [Next] [New Search]